Aoxing Pharmaceutical Company Inc Share Price Nyse
Equities
US03740A1060
Pharmaceuticals
Sales 2015 | 25.48M 2.04B | Sales 2016 | 32.33M 2.59B | Capitalization | 49.54M 3.96B |
---|---|---|---|---|---|
Net income 2015 | 5M 400M | Net income 2016 | 2M 160M | EV / Sales 2015 | 5.77 x |
Net Debt 2015 | 24.8M 1.98B | Net Debt 2016 | 18.56M 1.49B | EV / Sales 2016 | 2.11 x |
P/E ratio 2015 |
20.1
x | P/E ratio 2016 |
23.2
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 10/08/23 |
Gui Rong Zhou
CTO | Chief Tech/Sci/R&D Officer | 69 | 31/12/10 |
Peng Jiang
SAM | Sales & Marketing | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 10/08/23 |
1st Jan change | Capi. | |
---|---|---|
+19.27% | 43.18B | |
+24.05% | 23.23B | |
+15.11% | 14.6B | |
+12.33% | 13.54B | |
+38.36% | 11.5B | |
-7.63% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B |